nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—ABCC4—Sorafenib—thyroid cancer	0.28	0.364	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—thyroid cancer	0.223	0.289	CbGbCtD
Leucovorin—ABCC2—Sorafenib—thyroid cancer	0.167	0.216	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—thyroid cancer	0.101	0.131	CbGbCtD
Leucovorin—Disease progression—Sorafenib—thyroid cancer	0.0127	0.0679	CcSEcCtD
Leucovorin—Abdominal tenderness—Sorafenib—thyroid cancer	0.011	0.0586	CcSEcCtD
Leucovorin—Abdominal pain lower—Sorafenib—thyroid cancer	0.00874	0.0466	CcSEcCtD
Leucovorin—Caecitis—Epirubicin—thyroid cancer	0.00819	0.0437	CcSEcCtD
Leucovorin—Caecitis—Doxorubicin—thyroid cancer	0.00758	0.0404	CcSEcCtD
Leucovorin—Serum creatinine increased—Vandetanib—thyroid cancer	0.0067	0.0357	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.00407	0.124	CbGpPWpGaD
Leucovorin—TYMS—Erlotinib—Vandetanib—thyroid cancer	0.00403	0.449	CbGdCrCtD
Leucovorin—Lethargy—Vandetanib—thyroid cancer	0.00305	0.0163	CcSEcCtD
Leucovorin—Sensitisation—Epirubicin—thyroid cancer	0.00288	0.0153	CcSEcCtD
Leucovorin—Blood creatinine increased—Vandetanib—thyroid cancer	0.0028	0.0149	CcSEcCtD
Leucovorin—Sensitisation—Doxorubicin—thyroid cancer	0.00266	0.0142	CcSEcCtD
Leucovorin—TYMS—Afatinib—Vandetanib—thyroid cancer	0.00264	0.294	CbGdCrCtD
Leucovorin—Neuropathy—Sorafenib—thyroid cancer	0.00261	0.0139	CcSEcCtD
Leucovorin—TYMS—Gefitinib—Vandetanib—thyroid cancer	0.0023	0.257	CbGdCrCtD
Leucovorin—Stomatitis—Vandetanib—thyroid cancer	0.00225	0.012	CcSEcCtD
Leucovorin—Renal failure acute—Sorafenib—thyroid cancer	0.00219	0.0116	CcSEcCtD
Leucovorin—TYMS—G1/S-Specific Transcription—CDK1—thyroid cancer	0.00216	0.066	CbGpPWpGaD
Leucovorin—Kidney function abnormal—Epirubicin—thyroid cancer	0.00213	0.0113	CcSEcCtD
Leucovorin—Kidney function abnormal—Doxorubicin—thyroid cancer	0.00197	0.0105	CcSEcCtD
Leucovorin—Abdominal pain upper—Sorafenib—thyroid cancer	0.00184	0.00982	CcSEcCtD
Leucovorin—Alopecia—Vandetanib—thyroid cancer	0.00183	0.00975	CcSEcCtD
Leucovorin—Dysgeusia—Vandetanib—thyroid cancer	0.00176	0.0094	CcSEcCtD
Leucovorin—ABCC3—Recycling of bile acids and salts—RXRA—thyroid cancer	0.00174	0.0532	CbGpPWpGaD
Leucovorin—Febrile neutropenia—Epirubicin—thyroid cancer	0.00171	0.0091	CcSEcCtD
Leucovorin—Serum creatinine increased—Epirubicin—thyroid cancer	0.00167	0.0089	CcSEcCtD
Leucovorin—Loss of consciousness—Vandetanib—thyroid cancer	0.00158	0.00844	CcSEcCtD
Leucovorin—Febrile neutropenia—Doxorubicin—thyroid cancer	0.00158	0.00842	CcSEcCtD
Leucovorin—Convulsion—Vandetanib—thyroid cancer	0.00156	0.00832	CcSEcCtD
Leucovorin—Serum creatinine increased—Doxorubicin—thyroid cancer	0.00154	0.00824	CcSEcCtD
Leucovorin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00152	0.00812	CcSEcCtD
Leucovorin—Stomatitis—Sorafenib—thyroid cancer	0.00152	0.00808	CcSEcCtD
Leucovorin—Infection—Vandetanib—thyroid cancer	0.00146	0.00778	CcSEcCtD
Leucovorin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00144	0.00767	CcSEcCtD
Leucovorin—Skin disorder—Vandetanib—thyroid cancer	0.00143	0.00761	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00131	0.0401	CbGpPWpGaD
Leucovorin—Dyspnoea—Vandetanib—thyroid cancer	0.00131	0.00699	CcSEcCtD
Leucovorin—Dyspepsia—Vandetanib—thyroid cancer	0.00129	0.0069	CcSEcCtD
Leucovorin—Decreased appetite—Vandetanib—thyroid cancer	0.00128	0.00681	CcSEcCtD
Leucovorin—TYMS—E2F mediated regulation of DNA replication—CDK1—thyroid cancer	0.00127	0.0388	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00127	0.00676	CcSEcCtD
Leucovorin—Fatigue—Vandetanib—thyroid cancer	0.00127	0.00676	CcSEcCtD
Leucovorin—Rigors—Epirubicin—thyroid cancer	0.00126	0.00671	CcSEcCtD
Leucovorin—Constipation—Vandetanib—thyroid cancer	0.00126	0.0067	CcSEcCtD
Leucovorin—Alopecia—Sorafenib—thyroid cancer	0.00123	0.00657	CcSEcCtD
Leucovorin—Erythema—Sorafenib—thyroid cancer	0.00121	0.00648	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0012	0.00641	CcSEcCtD
Leucovorin—Dysgeusia—Sorafenib—thyroid cancer	0.00119	0.00634	CcSEcCtD
Leucovorin—Extravasation—Epirubicin—thyroid cancer	0.00118	0.00628	CcSEcCtD
Leucovorin—Rigors—Doxorubicin—thyroid cancer	0.00116	0.0062	CcSEcCtD
Leucovorin—Abdominal pain—Vandetanib—thyroid cancer	0.00116	0.00619	CcSEcCtD
Leucovorin—Body temperature increased—Vandetanib—thyroid cancer	0.00116	0.00619	CcSEcCtD
Leucovorin—Syncope—Sorafenib—thyroid cancer	0.00109	0.00581	CcSEcCtD
Leucovorin—Extravasation—Doxorubicin—thyroid cancer	0.00109	0.00581	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00109	0.0332	CbGpPWpGaD
Leucovorin—Leukopenia—Sorafenib—thyroid cancer	0.00109	0.0058	CcSEcCtD
Leucovorin—Loss of consciousness—Sorafenib—thyroid cancer	0.00107	0.00569	CcSEcCtD
Leucovorin—Asthenia—Vandetanib—thyroid cancer	0.00105	0.00562	CcSEcCtD
Leucovorin—Pruritus—Vandetanib—thyroid cancer	0.00104	0.00554	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00102	0.0312	CbGpPWpGaD
Leucovorin—Diarrhoea—Vandetanib—thyroid cancer	0.00101	0.00536	CcSEcCtD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.001	0.0306	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000992	0.00529	CcSEcCtD
Leucovorin—Infection—Sorafenib—thyroid cancer	0.000985	0.00525	CcSEcCtD
Leucovorin—Shock—Sorafenib—thyroid cancer	0.000975	0.0052	CcSEcCtD
Leucovorin—Dizziness—Vandetanib—thyroid cancer	0.000972	0.00518	CcSEcCtD
Leucovorin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000971	0.00518	CcSEcCtD
Leucovorin—Neuropathy—Epirubicin—thyroid cancer	0.000964	0.00514	CcSEcCtD
Leucovorin—Skin disorder—Sorafenib—thyroid cancer	0.000963	0.00513	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—TRIM33—thyroid cancer	0.000953	0.0291	CbGpPWpGaD
Leucovorin—Anorexia—Sorafenib—thyroid cancer	0.000945	0.00504	CcSEcCtD
Leucovorin—Vomiting—Vandetanib—thyroid cancer	0.000935	0.00498	CcSEcCtD
Leucovorin—Rash—Vandetanib—thyroid cancer	0.000927	0.00494	CcSEcCtD
Leucovorin—Dermatitis—Vandetanib—thyroid cancer	0.000926	0.00494	CcSEcCtD
Leucovorin—ABCC3—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000912	0.0278	CbGpPWpGaD
Leucovorin—Neuropathy—Doxorubicin—thyroid cancer	0.000892	0.00476	CcSEcCtD
Leucovorin—Dyspnoea—Sorafenib—thyroid cancer	0.000884	0.00471	CcSEcCtD
Leucovorin—Nausea—Vandetanib—thyroid cancer	0.000873	0.00465	CcSEcCtD
Leucovorin—Dyspepsia—Sorafenib—thyroid cancer	0.000873	0.00465	CcSEcCtD
Leucovorin—Decreased appetite—Sorafenib—thyroid cancer	0.000862	0.00459	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000856	0.00456	CcSEcCtD
Leucovorin—Fatigue—Sorafenib—thyroid cancer	0.000855	0.00456	CcSEcCtD
Leucovorin—Constipation—Sorafenib—thyroid cancer	0.000848	0.00452	CcSEcCtD
Leucovorin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000811	0.00432	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—thyroid cancer	0.000808	0.0043	CcSEcCtD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000794	0.0242	CbGpPWpGaD
Leucovorin—Urticaria—Sorafenib—thyroid cancer	0.000788	0.0042	CcSEcCtD
Leucovorin—Body temperature increased—Sorafenib—thyroid cancer	0.000784	0.00418	CcSEcCtD
Leucovorin—Abdominal pain—Sorafenib—thyroid cancer	0.000784	0.00418	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—thyroid cancer	0.000783	0.00418	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00077	0.00411	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—thyroid cancer	0.000761	0.00406	CcSEcCtD
Leucovorin—Renal failure acute—Doxorubicin—thyroid cancer	0.000747	0.00398	CcSEcCtD
Leucovorin—Hypersensitivity—Sorafenib—thyroid cancer	0.00073	0.00389	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—thyroid cancer	0.000725	0.00386	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000713	0.0038	CcSEcCtD
Leucovorin—Asthenia—Sorafenib—thyroid cancer	0.000711	0.00379	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—thyroid cancer	0.000704	0.00375	CcSEcCtD
Leucovorin—Pruritus—Sorafenib—thyroid cancer	0.000701	0.00374	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000698	0.00372	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000687	0.021	CbGpPWpGaD
Leucovorin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000681	0.00363	CcSEcCtD
Leucovorin—Diarrhoea—Sorafenib—thyroid cancer	0.000678	0.00362	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDK1—thyroid cancer	0.000674	0.0206	CbGpPWpGaD
Leucovorin—Dizziness—Sorafenib—thyroid cancer	0.000656	0.0035	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000646	0.00345	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—TCF7L1—thyroid cancer	0.000636	0.0194	CbGpPWpGaD
Leucovorin—Vomiting—Sorafenib—thyroid cancer	0.00063	0.00336	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00063	0.00336	CcSEcCtD
Leucovorin—Rash—Sorafenib—thyroid cancer	0.000625	0.00333	CcSEcCtD
Leucovorin—Dermatitis—Sorafenib—thyroid cancer	0.000625	0.00333	CcSEcCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000603	0.0184	CbGpPWpGaD
Leucovorin—Nausea—Sorafenib—thyroid cancer	0.000589	0.00314	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.000586	0.0179	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000563	0.003	CcSEcCtD
Leucovorin—Stomatitis—Epirubicin—thyroid cancer	0.00056	0.00299	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000521	0.00278	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—thyroid cancer	0.000518	0.00276	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CDK1—thyroid cancer	0.000489	0.0149	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000478	0.0146	CbGpPWpGaD
Leucovorin—Chills—Epirubicin—thyroid cancer	0.000463	0.00247	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—thyroid cancer	0.000456	0.00243	CcSEcCtD
Leucovorin—Erythema—Epirubicin—thyroid cancer	0.000449	0.00239	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—thyroid cancer	0.00044	0.00234	CcSEcCtD
Leucovorin—Chills—Doxorubicin—thyroid cancer	0.000428	0.00228	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—thyroid cancer	0.000422	0.00225	CcSEcCtD
Leucovorin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000417	0.00222	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—thyroid cancer	0.000415	0.00221	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDK1—thyroid cancer	0.000412	0.0126	CbGpPWpGaD
Leucovorin—Dysgeusia—Doxorubicin—thyroid cancer	0.000407	0.00217	CcSEcCtD
Leucovorin—Malaise—Epirubicin—thyroid cancer	0.000405	0.00216	CcSEcCtD
Leucovorin—Syncope—Epirubicin—thyroid cancer	0.000403	0.00215	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—thyroid cancer	0.000402	0.00214	CcSEcCtD
Leucovorin—Loss of consciousness—Epirubicin—thyroid cancer	0.000395	0.0021	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—thyroid cancer	0.000389	0.00207	CcSEcCtD
Leucovorin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000385	0.00205	CcSEcCtD
Leucovorin—Discomfort—Epirubicin—thyroid cancer	0.000378	0.00201	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—thyroid cancer	0.000375	0.002	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—thyroid cancer	0.000373	0.00199	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—thyroid cancer	0.000372	0.00198	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—thyroid cancer	0.000369	0.00197	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000366	0.00195	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000365	0.0111	CbGpPWpGaD
Leucovorin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000365	0.00195	CcSEcCtD
Leucovorin—Infection—Epirubicin—thyroid cancer	0.000364	0.00194	CcSEcCtD
Leucovorin—Shock—Epirubicin—thyroid cancer	0.000361	0.00192	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—thyroid cancer	0.00036	0.00192	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000359	0.00191	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—thyroid cancer	0.000356	0.0019	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC5A5—thyroid cancer	0.000354	0.0108	CbGpPWpGaD
Leucovorin—Discomfort—Doxorubicin—thyroid cancer	0.000349	0.00186	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—thyroid cancer	0.000349	0.00186	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000349	0.0107	CbGpPWpGaD
Leucovorin—Confusional state—Doxorubicin—thyroid cancer	0.000342	0.00182	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000339	0.00181	CcSEcCtD
Leucovorin—Infection—Doxorubicin—thyroid cancer	0.000337	0.0018	CcSEcCtD
Leucovorin—Shock—Doxorubicin—thyroid cancer	0.000334	0.00178	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC5A5—thyroid cancer	0.000333	0.0102	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000332	0.00177	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—thyroid cancer	0.000329	0.00176	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—thyroid cancer	0.000327	0.00174	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—PCM1—thyroid cancer	0.000327	0.00997	CbGpPWpGaD
Leucovorin—Anorexia—Doxorubicin—thyroid cancer	0.000323	0.00172	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—thyroid cancer	0.000323	0.00172	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—thyroid cancer	0.000319	0.0017	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000316	0.00169	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—thyroid cancer	0.000316	0.00168	CcSEcCtD
Leucovorin—Constipation—Epirubicin—thyroid cancer	0.000313	0.00167	CcSEcCtD
Leucovorin—Dyspnoea—Doxorubicin—thyroid cancer	0.000302	0.00161	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—thyroid cancer	0.000302	0.00161	CcSEcCtD
Leucovorin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.0003	0.0016	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—thyroid cancer	0.000298	0.00159	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—RXRA—thyroid cancer	0.000298	0.00908	CbGpPWpGaD
Leucovorin—Decreased appetite—Doxorubicin—thyroid cancer	0.000295	0.00157	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000293	0.00156	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—thyroid cancer	0.000292	0.00156	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—thyroid cancer	0.000291	0.00155	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—thyroid cancer	0.00029	0.00155	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00029	0.00885	CbGpPWpGaD
Leucovorin—Body temperature increased—Epirubicin—thyroid cancer	0.00029	0.00154	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—thyroid cancer	0.00029	0.00154	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000289	0.00882	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	0.000281	0.00857	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—RXRA—thyroid cancer	0.00028	0.00854	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000279	0.00149	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000277	0.00847	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000277	0.00148	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000272	0.00829	CbGpPWpGaD
Leucovorin—Hypersensitivity—Epirubicin—thyroid cancer	0.00027	0.00144	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—thyroid cancer	0.000269	0.00144	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—thyroid cancer	0.000268	0.00143	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—thyroid cancer	0.000268	0.00143	CcSEcCtD
Leucovorin—Asthenia—Epirubicin—thyroid cancer	0.000263	0.0014	CcSEcCtD
Leucovorin—Pruritus—Epirubicin—thyroid cancer	0.000259	0.00138	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—NRG1—thyroid cancer	0.000257	0.00785	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—thyroid cancer	0.000251	0.00134	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—thyroid cancer	0.00025	0.00133	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000244	0.00745	CbGpPWpGaD
Leucovorin—Asthenia—Doxorubicin—thyroid cancer	0.000243	0.0013	CcSEcCtD
Leucovorin—Dizziness—Epirubicin—thyroid cancer	0.000242	0.00129	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—NRG1—thyroid cancer	0.000242	0.00738	CbGpPWpGaD
Leucovorin—Pruritus—Doxorubicin—thyroid cancer	0.00024	0.00128	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—RXRA—thyroid cancer	0.000236	0.0072	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—thyroid cancer	0.000233	0.00124	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—thyroid cancer	0.000232	0.00124	CcSEcCtD
Leucovorin—TYMS—Metabolism—MINPP1—thyroid cancer	0.000232	0.00707	CbGpPWpGaD
Leucovorin—Rash—Epirubicin—thyroid cancer	0.000231	0.00123	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—thyroid cancer	0.000231	0.00123	CcSEcCtD
Leucovorin—Dizziness—Doxorubicin—thyroid cancer	0.000224	0.0012	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000223	0.00681	CbGpPWpGaD
Leucovorin—Nausea—Epirubicin—thyroid cancer	0.000218	0.00116	CcSEcCtD
Leucovorin—Vomiting—Doxorubicin—thyroid cancer	0.000216	0.00115	CcSEcCtD
Leucovorin—Rash—Doxorubicin—thyroid cancer	0.000214	0.00114	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—thyroid cancer	0.000214	0.00114	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—NRG1—thyroid cancer	0.000204	0.00622	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—thyroid cancer	0.000201	0.00107	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—TPR—thyroid cancer	0.0002	0.00609	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NDUFA13—thyroid cancer	0.000197	0.00601	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MINPP1—thyroid cancer	0.000192	0.00585	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CHST14—thyroid cancer	0.000185	0.00565	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PPARG—thyroid cancer	0.000176	0.00536	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—thyroid cancer	0.000172	0.00524	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NDUFA13—thyroid cancer	0.000163	0.00497	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PRKAR1A—thyroid cancer	0.000162	0.00494	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000161	0.00491	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CHST14—thyroid cancer	0.000153	0.00468	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000151	0.00462	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000151	0.00462	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000151	0.00461	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—HPGD—thyroid cancer	0.000149	0.00455	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000149	0.00455	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000144	0.00439	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000142	0.00435	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000142	0.00435	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00014	0.00428	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDK1—thyroid cancer	0.000135	0.00413	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.00013	0.00397	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000126	0.00383	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—HPGD—thyroid cancer	0.000124	0.00377	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PTEN—thyroid cancer	0.000121	0.00368	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00012	0.00367	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	0.00012	0.00367	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000118	0.00361	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000113	0.00346	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNA2—thyroid cancer	0.000107	0.00327	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000107	0.00325	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.0001	0.00306	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TERT—thyroid cancer	9.74e-05	0.00297	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.64e-05	0.00294	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.53e-05	0.00291	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.99e-05	0.00274	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.96e-05	0.00273	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—TPR—thyroid cancer	8.57e-05	0.00262	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.57e-05	0.00262	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PRKAR1A—thyroid cancer	8.43e-05	0.00257	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—thyroid cancer	8.23e-05	0.00251	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.55e-05	0.00231	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.24e-05	0.00221	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TPR—thyroid cancer	7.1e-05	0.00217	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PRKAR1A—thyroid cancer	6.98e-05	0.00213	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC5A5—thyroid cancer	6.42e-05	0.00196	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.33e-05	0.00193	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—thyroid cancer	6.3e-05	0.00192	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—thyroid cancer	5.63e-05	0.00172	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RXRA—thyroid cancer	5.39e-05	0.00165	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC5A5—thyroid cancer	5.31e-05	0.00162	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	5.01e-05	0.00153	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.98e-05	0.00152	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RXRA—thyroid cancer	4.46e-05	0.00136	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.34e-05	0.00132	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—thyroid cancer	4e-05	0.00122	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—thyroid cancer	3.71e-05	0.00113	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—thyroid cancer	3.44e-05	0.00105	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPARG—thyroid cancer	3.4e-05	0.00104	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—thyroid cancer	3.06e-05	0.000934	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—thyroid cancer	2.93e-05	0.000893	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPARG—thyroid cancer	2.82e-05	0.00086	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—thyroid cancer	2.68e-05	0.000817	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—thyroid cancer	2.58e-05	0.000788	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTEN—thyroid cancer	2.34e-05	0.000713	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—thyroid cancer	2.22e-05	0.000676	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTEN—thyroid cancer	1.93e-05	0.00059	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—thyroid cancer	1.35e-05	0.000411	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—thyroid cancer	1.11e-05	0.00034	CbGpPWpGaD
